Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Irbesartan 300mg	58
Overall Study	STARTED	Placebo	59
Overall Study	STARTED	PS433540 200mg	58
Overall Study	STARTED	PS433540 400mg	58
Overall Study	STARTED	PS433540 800mg	28
Overall Study	COMPLETED	Irbesartan 300mg	44
Overall Study	COMPLETED	Placebo	39
Overall Study	COMPLETED	PS433540 200mg	55
Overall Study	COMPLETED	PS433540 400mg	48
Overall Study	COMPLETED	PS433540 800mg	20
Overall Study	NOT COMPLETED	Irbesartan 300mg	14
Overall Study	NOT COMPLETED	Placebo	20
Overall Study	NOT COMPLETED	PS433540 200mg	3
Overall Study	NOT COMPLETED	PS433540 400mg	10
Overall Study	NOT COMPLETED	PS433540 800mg	8

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00635232/flow